Cargando…
Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver
Surgical excision remains the preferred treatment for resectable hepatic metastases of neuroendocrine tumors. In cases of more disseminated hepatic disease, transarterial radioembolization with Yttrium-90- (90Y-) labeled microspheres has been demonstrated as a viable option for symptom and locoregio...
Autores principales: | Vyleta, Martin, Coldwell, Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253440/ https://www.ncbi.nlm.nih.gov/pubmed/22235376 http://dx.doi.org/10.4061/2011/785315 |
Ejemplares similares
-
The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases
por: Ramdhani, Khalil, et al.
Publicado: (2022) -
Radioembolization treatment for liver metastases
por: Kiszkaą, Joanna, et al.
Publicado: (2017) -
Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
por: Tsang, Erica S., et al.
Publicado: (2020) -
Treatment of Neuroendocrine Tumor Liver Metastases
por: Lewis, Mark A., et al.
Publicado: (2012) -
Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
por: Loree, Jonathan M., et al.
Publicado: (2016)